Global Nutrigenomics Market Size to Reach USD 2,351.33 Million in 2032 | Emergen Research

Vancouver, Oct. 18, 2023 (GLOBE NEWSWIRE) -- The global nutrigenomics market size is expected to reach USD 2,351.33 Million in 2032 and register a steady CAGR over the forecast period, according to latest analysis by Emergen Research. Market revenue growth is primarily driven by rising prevalence of obesity and cardiovascular diseases due to sedentary lifestyle and changing food habits.

 According to the World Health Organization (WHO), Cardiovascular Diseases (CVDs) are the leading cause of deaths globally. As estimated 17.9 million people died from cardiovascular diseases in 2019, which represents almost 32% of all global deaths. More than four out of five cardiovascular deaths are due to strokes and heart attacks, and one-third of these deaths occur prematurely in individuals under 70 years of age. Majority of heart diseases can be prevented with healthy lifestyle choices and by maintaining a personalized diet.

Download Free Exclusive Sample PDF @ https://www.emergenresearch.com/request-sample/787

Rising importance of nutritious food and personalized diet in order to minimize risk of chronic diseases such as cardiovascular diseases, obesity, cancers, and type 2 diabetes is expected to boost revenue growth of the market during the forecast period. Rising popularity of personalized nutrition among athletes is also driving market growth.

Shift from one-size-fits-all group approach towards personalization of diets among sport dietitians and nutritionists is fueling demand for nutrigenomics testing in the sports industry. Establishment of pan-national organizations is expected to increase international collaborations around nutrigenomics research. Rising number of diet related disorders in developing countries is also boosting research and development activities related to nutrigenomics.

Scope of Research

Emergen Research is Offering Limited Time Discount (Grab a Copy at Discounted Price Now) @ https://www.emergenresearch.com/request-discount/787

MAJOR COMPANIES and Competitive Landscape

The global nutrigenomics market is consolidated with a few major players accounting for majority market revenue. Companies are focusing on strategic expansion into untapped markets and on research and development initiatives to develop products based on personalized nutrition in order to secure and maintain a robust position in the rapidly growing market. Some major players operating in the global nutrigenomics market include:

• Koninklijke DSM N.V.
• BASF SE
• Danone S.A.
• Unilever plc
• Genova Diagnostics
• Nutrigenomix Inc.
• Metagenics, Inc.
• GX Sciences Inc
• Cell-Logic
• Xcode Life

Strategic development

In April 2019, Nutrigenomix Inc., which is a leader in genetic testing personalized nutrition, launched new genetic test for plant-based personalized nutrition, which is suitable for vegans and vegetarians. The new line of genetic test is an addition to the wide range of testing kits offered by the company. It provides actionable genetic information, which helps healthcare professionals in recommending a suitable personalized diet to patients for attaining optimal health, performance, and wellness. The new test includes genetic markers like the other test, which includes gluten intolerance, nutrient metabolism, eating behaviors, weight management, cardiometabolic health, and fitness, with additional advice specifically for vegans and vegetarians.

Direct Order Can Be Placed Through This Link [Exclusive Copy] @ https://www.emergenresearch.com/select-license/787

Some Key Highlights From the Report

• In July 2019, GX Sciences announced the launch of GX Sciences Asia, which would be based in Hong Kong, China. The new global expansion is expected to help the company in accelerating growth in the laboratory / biotechnology medical space. The purpose behind the expansion is to promote growth of genetic testing into the Asian market and continue research regarding personalized medicine and ability to determine unique metabolic needs of patient. The company is expecting to witness the positive impact of nutrigenomics in Asia Pacific.
• Obesity segment accounted for largest revenue share in 2020. Ability of nutrigenomic testing to suggest a personalized diet based on individual’s genetic, phenotypic, and medical information, which would help in reducing obesity, is expected to contribute to its increasing application.
• Reagents and kits segment revenue is expected to expand at a rapid CAGR during the forecast period. Shift from one-size-fits-all group approach towards personalization of diet among the sport dietitians and nutritionists is expected to boost demand for testing kits.
• Revenue from the nutrigenomics market in Asia Pacific is expected to expand at a rapid rate during the forecast period. Increasing number of diet-related disorders in India such as obesity, neural tube defects, diabetes, and cardio-vascular diseases is resulting in increasing nutrigenomics research in the region.

Browse Full Report Description + Research Methodology + Table of Content + Infographics @ https://www.emergenresearch.com/industry-report/nutrigenomics-market

For the purpose of this report, Emergen Research has segmented the global nutrigenomics market on the basis of application, product, and region: 

• Application Outlook (Revenue, USD Million; 2019–2032)
  • Cardiovascular Diseases
  • Cancer Research
  • Obesity
  • Diabetes
  • Others

• Product Outlook (Revenue, USD Million; 2019–2032)
  • Reagents and Kits
  • Services                       

• Regional Outlook (Revenue, USD Million; 2019–2032)
  • North America
    1. U.S.
    2. Canada
    3. Mexico
  • Europe
    1. Germany
    2. France
    3. U.K.
    4. BENELUX
    5. Italy
    6. Spain
    7. Rest of Europe
  • Asia Pacific
    1. China
    2. Japan
    3. South Korea
    4. India
    5. Rest of APAC
  • Latin America
    1. Brazil
    2. Rest of LATAM
  • Middle East & Africa
    1. Saudi Arabia
    2. UAE
    3. South Africa
    4. Rest of MEA

Curated Reports You Shouldn't Miss: Dive In Now!

Global Non-Invasive Prenatal Testing Market By Method, By End-Use, By Application, By Region, Forecasts to 2017-2027

Orthopedics Devices Market By Product, By Type (Joint Reconstruction, Spinal, Trauma, Arthroscopy, Dental Implants, Orthobiologics), By Application (Hip, Knee, Spine, Cranio-Maxillofacial (CMF), Dental, Sports Medical, Extremities, and Trauma (SET)), Forecasts to 2027

Radiation Dose Management Market, By Product (Dosimeters, Area Process Monitors), By Component (Software, Service), By Application (Radiography, Angiography, Mammography), and By Region Forecast to 2030

In Vitro Fertilization Market Size, Share, Trends, By Procedure (Fresh Donor, Fresh Non-Donor, Frozen Donor, Frozen Non-Donor), By Product (Reagents, Equipment), By End-use (Hospitals and Research Laboratories, Fertility Clinics and Surgical Centers, Cryobanks), and By Region Forecast to 2028

Direct-To-Consumer Genetic Testing Market, By Test Type (Carrier Testing and Predictive Testing), By Technology (Targeted Analysis and Whole Genome Sequencing), and By Region Forecast to 2030

About Emergen Research

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web: https://www.emergenresearch.com/

Direct Line: +1 (604) 757-9756

E-mail: sales@emergenresearch.com

Explore Our Japanese Version: Nutrigenomics Market

Explore Our Blogs and Insights Section: https://www.emergenresearch.com/insights

Read our Press Release @ https://www.emergenresearch.com/press-release/global-nutrigenomics-market